Duchenne muscular dystrophy:
- 19 April 2012
AVI Biopharma release new results from phase 2b exon skipping trial AVI Biopharma has announced preliminary results of their phase 2b study of Eteplirsen for Duchenne muscular dystrophy. - 5 April 2012
New drug a potential treatment for Duchenne muscular dystrophy Scientists have shown that increasing the amount of a protein called heat shock protein 72 can have a beneficial effect in a mouse model of Duchenne muscular dystrophy. - 14 March 2012
Update on BIO-NMD: A research project looking into Duchenne, Becker, Ullrich and Bethlem muscular dystrophies An update on the progress of BIO-NMD - an EU funded project searching for biomarkers - 2 March 2012
Supporting families and parents through diagnosis The diagnosis process can be daunting, the Muscular Dystrophy Campaign can offer vital support and advice to guide you through this difficult time. - 14 February 2012
Clinical trial plans announced for utrophin drug for Duchenne Summit has outlined plans to test a drug for Duchenne and Becker muscular dystrophies - a phase 1 trial will start soon and results should be available before the end of this year. - 13 February 2012
Update on ataluren extension trial for Duchenne PTC Therapeutics expects that most study centres involved in the ataluren extension trial in the UK, continental Europe, Israel and Australia will open between March and June this year. - 5 January 2012
Newborn screening for Duchenne out to consultation An application for Duchenne muscular dystrophy to be included in the newborn screening programme is now out for consultation - fill out our survey to have your say. - 19 December 2011
Summit secures funding for utrophin drug for Duchenne Summit plc has secured £1 million worth of funding from several US-based charities to manufacture a new formulation of a potential drug for Duchenne and Becker muscular dystrophies and conduct a Phase 1 clinical trial. - 7 December 2011
Lloyd family become X-Factor stars The Lloyd family from Wirral were the stars on the TV show X Factor on Sunday when a film featuring three young brothers with Duchenne Muscular Dystrophy was shown to viewers. - 30 November 2011
Ataluren extension trial for Duchenne about to start PTC Therapeutics has affirmed their commitment to develop ataluren to treat boys with Duchenne muscular dystrophy and announced progress in starting an extension trial in the UK, Europe, Israel and Australia.
